[CLSTR]
< Back to situations

[ORGANIZATION]

University of Colorado Anschutz

Featured in 11 tracked stories · first seen

Situations

[ACTIVE] [HEALTH] [US] [BR] [GB]

GLP-1 drugs: clinical trends, safety, and market shifts

282 clusters · 1067 sources · last updated

Latest: Glp-1 weight management drug consumption in Italy rises 85.7%

Since mid-2026, the expansion of GLP-1 agents for obesity has been accompanied by intensified safety monitoring and evolving clinical data. Research suggests secondary benefits, including a 21% lower risk of fragility fr

[ACTIVE] [HEALTH] [US] [GB] [SE]

Expanded therapeutic research and management of GLP-1 drugs

20 clusters · 119 sources · last updated

Latest: Semaglutide and insulin combination shows clinical benefits for type 2 diabetes

Medical research continues to expand the known therapeutic potential of GLP-1 receptor agonists like semaglutide and tirzepatide. Beyond diabetes and obesity, these medications are being linked to mental health, respirat

[QUIET] [HEALTH] [CA] [US]

Cannabis edible consumption and driving impairment

2 clusters · 5 sources · last updated

Latest: Cannabis edibles impair driving even when blood THC levels are low

A study published in ‘JAMA Network Open’ has identified that cannabis edibles, such as THC gummies, significantly impair driving ability even several hours after consumption. Research conducted at a Canadian hospital inv

Also covered in